Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber R. Cornelius, View ORCID ProfileSophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley Hyman, Michael Tuen, View ORCID ProfileSergei B. Koralov, View ORCID ProfileMark J. Mulligan, View ORCID ProfileRamin Sedaghat Herati
doi: https://doi.org/10.1101/2021.02.07.21251311
Marie I. Samanovic
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Amber R. Cornelius
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sophie L. Gray-Gaillard
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Joseph Richard Allen
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Trishala Karmacharya
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Jimmy P. Wilson
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sara Wesley Hyman
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Michael Tuen
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sergei B. Koralov
2Department of Pathology, New York University School of Medicine; New York, NY, USA
Mark J. Mulligan
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Ramin Sedaghat Herati
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data from this study is available upon request.
Posted August 31, 2021.
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber R. Cornelius, Sophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley Hyman, Michael Tuen, Sergei B. Koralov, Mark J. Mulligan, Ramin Sedaghat Herati
medRxiv 2021.02.07.21251311; doi: https://doi.org/10.1101/2021.02.07.21251311
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber R. Cornelius, Sophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley Hyman, Michael Tuen, Sergei B. Koralov, Mark J. Mulligan, Ramin Sedaghat Herati
medRxiv 2021.02.07.21251311; doi: https://doi.org/10.1101/2021.02.07.21251311
Subject Area
Subject Areas
- Addiction Medicine (326)
- Allergy and Immunology (641)
- Anesthesia (170)
- Cardiovascular Medicine (2452)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11894)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3826)
- Geriatric Medicine (356)
- Health Economics (646)
- Health Informatics (2469)
- Health Policy (953)
- Hematology (348)
- HIV/AIDS (806)
- Medical Education (379)
- Medical Ethics (105)
- Nephrology (409)
- Neurology (3591)
- Nursing (202)
- Nutrition (536)
- Oncology (1863)
- Ophthalmology (544)
- Orthopedics (227)
- Otolaryngology (293)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (457)
- Pediatrics (1057)
- Primary Care Research (432)
- Public and Global Health (6255)
- Radiology and Imaging (1317)
- Respiratory Medicine (842)
- Rheumatology (387)
- Sports Medicine (332)
- Surgery (417)
- Toxicology (51)
- Transplantation (177)
- Urology (149)